BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3224193)

  • 1. Economical with the truth? What to tell the patient in a clinical trial.
    Johns A
    Br J Addict; 1988 Sep; 83(9):1115-7. PubMed ID: 3224193
    [No Abstract]   [Full Text] [Related]  

  • 2. Truth in Advertising: Do Clinical Trial Publications Tell It All?
    Khan MK; Buchwald ZS; Mourad WF
    J Natl Compr Canc Netw; 2017 Nov; 15(11):1439-1440. PubMed ID: 29118235
    [No Abstract]   [Full Text] [Related]  

  • 3. Nocebo side-effects in cancer treatment.
    Garg AK
    Lancet Oncol; 2011 Dec; 12(13):1181-2. PubMed ID: 21944597
    [No Abstract]   [Full Text] [Related]  

  • 4. Do effectiveness studies tell us the real truth?
    Möller HJ
    World J Biol Psychiatry; 2007; 8(3):138-40. PubMed ID: 17654406
    [No Abstract]   [Full Text] [Related]  

  • 5. Don't ask, don't tell.
    Sussman S
    Subst Use Misuse; 2004; 39(10-12):2081-2. PubMed ID: 15587963
    [No Abstract]   [Full Text] [Related]  

  • 6. The truth about homeopathy.
    Ernst E
    Br J Clin Pharmacol; 2008 Feb; 65(2):163-4. PubMed ID: 17875194
    [No Abstract]   [Full Text] [Related]  

  • 7. How to measure outcome in clinical trials of substance abuse treatment.
    Uchtenhagen A
    Addiction; 2012 Apr; 107(4):720-2. PubMed ID: 22372699
    [No Abstract]   [Full Text] [Related]  

  • 8. Other outcomes in treatments for substance-use disorders: a call for action.
    Tiffany ST; Friedman L; Greenfield SF; Hasin DS; Jackson R
    Addiction; 2012 Apr; 107(4):725-6. PubMed ID: 22372702
    [No Abstract]   [Full Text] [Related]  

  • 9. Do we always need to tell patients the truth?
    Simone CB; Simone NL; Simone CB
    Lancet; 1998 Nov; 352(9142):1787. PubMed ID: 9848386
    [No Abstract]   [Full Text] [Related]  

  • 10. Should we tell trial patients that they might receive placebo?
    Skovlund E
    Lancet; 1991 Apr; 337(8748):1041. PubMed ID: 1673192
    [No Abstract]   [Full Text] [Related]  

  • 11. The mountain roared and brought forth a mouse*: comments on the results of an expert panel on standardization of drug dependence treatment trial outcome variables.
    Bühringer G
    Addiction; 2012 Apr; 107(4):722-3. PubMed ID: 22372700
    [No Abstract]   [Full Text] [Related]  

  • 12. Information for patients.
    Ransome O
    S Afr Med J; 2007 Dec; 97(12):1231-2. PubMed ID: 18264599
    [No Abstract]   [Full Text] [Related]  

  • 13. Cycles of evasion.
    Lyall J
    Nurs Times; 1990 Aug 22-28; 86(34):16-7. PubMed ID: 2395676
    [No Abstract]   [Full Text] [Related]  

  • 14. Should you tell patients about beneficial treatments that they cannot have? No.
    Firth J
    BMJ; 2007 Apr; 334(7598):827. PubMed ID: 17446612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To tell the truth: potential liability for concealing physician impairment.
    Liang BA
    J Clin Anesth; 2007 Dec; 19(8):638-9; discussion 639-41. PubMed ID: 18083483
    [No Abstract]   [Full Text] [Related]  

  • 16. Fat chance of measuring food intake accurately.
    Winkler JT
    Nature; 2004 Jul; 430(6996):141. PubMed ID: 15241388
    [No Abstract]   [Full Text] [Related]  

  • 17. Should you tell patients about beneficial treatments that they cannot have? Yes.
    Marcus R
    BMJ; 2007 Apr; 334(7598):826. PubMed ID: 17446611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Side effects of talking with patients].
    Rief W
    MMW Fortschr Med; 2011 Sep; 153(39):31-4. PubMed ID: 21991833
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of the impaired person in the OR.
    Hyde GL
    Plast Surg Nurs; 1990; 10(2):77-9, 91. PubMed ID: 2381989
    [No Abstract]   [Full Text] [Related]  

  • 20. What should we tell patients with cancer?
    Reid A; Bennett-Emslie G; Adams L; Kaye SB
    Scott Med J; 1988 Jun; 33(3):260. PubMed ID: 3175602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.